Holger Bang

5.9k total citations · 1 hit paper
65 papers, 3.3k citations indexed

About

Holger Bang is a scholar working on Molecular Biology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Holger Bang has authored 65 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Rheumatology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Holger Bang's work include Rheumatoid Arthritis Research and Therapies (25 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Signaling Pathways in Disease (17 papers). Holger Bang is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Signaling Pathways in Disease (17 papers). Holger Bang collaborates with scholars based in Germany, Netherlands and Austria. Holger Bang's co-authors include Gunter Fischer, Kay Brune, Mohamed A. Marahiel, Georg Schett, G. Fischer, Gerald Willimsky, Edith Berger, René E. M. Toes, Andreas Pahl and Eugen Feist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Holger Bang

65 papers receiving 3.2k citations

Hit Papers

Induction of osteoclastog... 2012 2026 2016 2021 2012 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Holger Bang 1.7k 1.1k 891 562 516 65 3.3k
Tony N. Marion 1.1k 0.7× 826 0.8× 1.9k 2.1× 904 1.6× 438 0.8× 77 3.3k
George M. C. Janssen 2.3k 1.3× 593 0.5× 915 1.0× 499 0.9× 389 0.8× 82 4.1k
Yonghua Sheng 950 0.6× 658 0.6× 666 0.7× 317 0.6× 164 0.3× 46 2.5k
Benjamin D. Schwartz 1.1k 0.7× 412 0.4× 1.6k 1.8× 775 1.4× 242 0.5× 91 3.8k
Bernard J. Scallon 1.3k 0.8× 633 0.6× 1.5k 1.6× 1.0k 1.8× 368 0.7× 38 3.9k
Alison Finnegan 1.4k 0.8× 1.1k 1.0× 2.8k 3.1× 689 1.2× 993 1.9× 91 5.6k
Antonio Nieto 770 0.5× 382 0.3× 780 0.9× 169 0.3× 557 1.1× 141 3.0k
Charles F. Reich 1.2k 0.7× 322 0.3× 1.4k 1.6× 184 0.3× 219 0.4× 55 2.8k
Yoann Rombouts 1.7k 1.0× 423 0.4× 1.1k 1.3× 1.1k 2.0× 163 0.3× 55 2.8k
Nadine L. Dudek 900 0.5× 449 0.4× 2.3k 2.5× 412 0.7× 407 0.8× 42 3.9k

Countries citing papers authored by Holger Bang

Since Specialization
Citations

This map shows the geographic impact of Holger Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Bang more than expected).

Fields of papers citing papers by Holger Bang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Bang. The network helps show where Holger Bang may publish in the future.

Co-authorship network of co-authors of Holger Bang

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Bang. A scholar is included among the top collaborators of Holger Bang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Bang. Holger Bang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ju‐Yeon, et al.. (2024). Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review). Oncology Letters. 29(2). 93–93. 3 indexed citations
2.
Sokolova, Maria, F Hartmann, Daniela Sieghart, et al.. (2023). Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk. RMD Open. 9(1). e002705–e002705. 8 indexed citations
3.
Westerlind, Helga, Alf Kastbom, Johan Rönnelid, et al.. (2022). The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis. Lara D. Veeken. 62(6). 2106–2112. 4 indexed citations
4.
Kissel, Theresa, Gerrie Stoeken‐Rijsbergen, Linda M. Slot, et al.. (2021). Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load. Arthritis Research & Therapy. 23(1). 230–230. 16 indexed citations
5.
Kissel, Theresa, Marco Cavallari, Gerrie Stoeken‐Rijsbergen, et al.. (2020). Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Annals of the Rheumatic Diseases. 79(4). 472–480. 80 indexed citations
6.
Bang, Holger, Laura Nuño, Diana Peiteado, et al.. (2020). Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies. Scientific Reports. 10(1). 19263–19263. 10 indexed citations
7.
Bang, Holger, Melanie Hagen, Michael Frech, et al.. (2019). The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study. Nutrients. 11(10). 2392–2392. 100 indexed citations
8.
Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2019). In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Research & Therapy. 21(1). 28–28. 45 indexed citations
9.
Bözec, Aline, Yubin Luo, Cecilia Engdahl, et al.. (2018). Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner. Arthritis Research & Therapy. 20(1). 24–24. 43 indexed citations
10.
Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2018). Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes. Arthritis Research & Therapy. 20(1). 33–33. 37 indexed citations
11.
Ospelt, Caroline, Holger Bang, Eugen Feist, et al.. (2017). Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis. Annals of the Rheumatic Diseases. 76(7). 1176–1183. 59 indexed citations
12.
Ljung, Lotta, Karl Egerer, Holger Bang, et al.. (2011). New Assay Generation for Antibodies Against Modified and Citrullinated Peptides Predicts Poor Response to TNF Inhibitor Therapy. Arthritis & Rheumatism. 63(10). 1 indexed citations
13.
Bang, Holger, Eugen Feist, G Fredenhagen, et al.. (2010). Immediate determination of ACPA and rheumatoid factor - a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay. Arthritis Research & Therapy. 12(3). R120–R120. 21 indexed citations
14.
Köllermann, Jens, Thorsten Schlomm, Holger Bang, et al.. (2008). Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer. European Urology. 54(6). 1314–1323. 80 indexed citations
15.
Kiessig, Steffen, Holger Bang, & Frank Thunecke. (1999). Interaction of cyclophilin and cyclosporins monitored by affinity capillary electrophoresis. Journal of Chromatography A. 853(1-2). 469–477. 31 indexed citations
16.
Schölz, Christian, Michael Rapé, Michael Pecht, et al.. (1998). Recognition of protein substrates by the prolyl isomerase trigger factor is independent of proline residues 1 1Edited by P. E. Wright. Journal of Molecular Biology. 277(3). 723–732. 36 indexed citations
17.
Bang, Holger, et al.. (1998). Modulation of transcription factor NF‐κB by enantiomers of the nonsteroidal drug ibuprofen. British Journal of Pharmacology. 123(4). 645–652. 74 indexed citations
18.
Pahl, Andreas, Kay Brune, & Holger Bang. (1997). Fit for life? Evolution of chaperones and folding catalysts parallels the development of complex organisms. Cell Stress and Chaperones. 2(2). 78–78. 11 indexed citations
19.
Tegeder, Irmgard, Axel Schumacher, Hartmut Geiger, et al.. (1997). Elevated Serum Cyclophilin Levels in Patients with Severe Sepsis. Journal of Clinical Immunology. 17(5). 380–386. 85 indexed citations
20.
Bang, Holger, et al.. (1993). Interleukin-8 is a Cyclosporin A binding protein. Cellular and Molecular Life Sciences. 49(6-7). 533–538. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026